Loading...

FITC anti-mouse CD8a Antibody

Pricing & Availability
Clone
53-6.7 (See other available formats)
Regulatory Status
RUO
Other Names
T8, Lyt2, Ly-2
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
53-6.7_FITC_102110
C57BL/6 mouse splenocytes were stained with CD8 (clone 53-6.7) FITC (filled histogram) or rat IgG2a, κ FITC isotype control (open histogram).
  • 53-6.7_FITC_102110
    C57BL/6 mouse splenocytes were stained with CD8 (clone 53-6.7) FITC (filled histogram) or rat IgG2a, κ FITC isotype control (open histogram).
See FITC spectral data
Cat # Size Price Quantity Check Availability Save
100705 50 µg $30
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100706 500 µg $99
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD8, also known as Lyt-2, Ly-2, or T8, consists of disulfide-linked α and β chains that form the α(CD8a)/β(CD8b) heterodimer and α/α homodimer. CD8a is a 34 kD protein that belongs to the immunoglobulin family. The CD8 α/β heterodimer is expressed on the surface of most thymocytes and a subset of mature TCR α/β T cells. CD8 expression on mature T cells is non-overlapping with CD4. The CD8 α/α homodimer is expressed on a subset of γ/δ TCR-bearing T cells, NK cells, intestinal intraepithelial lymphocytes, and lymphoid dendritic cells. CD8 is an antigen co-receptor on T cells that interacts with MHC class I on antigen-presenting cells or epithelial cells. CD8 promotes T cell activation through its association with the TCR complex and protein tyrosine kinase lck.

Product Details
Technical data sheet

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The CD8a antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone 53-6.7 antibody competes with clone 5H10-1 antibody for binding to thymocytes3. The 53-6.7 antibody has been reported to block antigen presentation via MHC class I and inhibit T cell responses to IL-2. This antibody has also been used for depletion of CD8a+ cells. Additional reported applications (for the relevant formats) include: immunoprecipitation1,3, in vivo and in vitro cell depletion2,10,15, inhibition of CD8 T cell proliferation3, blocking of cytotoxicity3,4, immunohistochemical staining5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, and spatial biology (IBEX)29,30. Clone 53-6.7 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays or in vivo studies (Cat No. 100746).

Application References

(PubMed link indicates BioLegend citation)
  1. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IHC, IP)
  2. Hathcock KS. 1991. Current Protocols in Immunology. 3.4.1. (Deplete)
  3. Takahashi K, et al. 1992. P. Natl. Acad. Sci. USA 89:5557. (Block, IP)
  4. Ledbetter JA, et al. 1981. J. Exp. Med. 153:1503. (Block)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Kamimura D, et al. 2006. J. Immunol. 177:306.
  9. Bouwer HGA, et al. 2006. P. Natl. Acad. Sci. USA 103:5102. (FC, Deplete)
  10. Kao C, et al. 2005. Int. Immunol. 17:1607. PubMed
  11. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
  12. Rasmussen JW, et al. 2006. Infect. Immun. 74:6590. PubMed
  13. Lee CH, et al. 2009. Clin. Cancer Res. PubMed
  14. Geiben-Lynn R, et al. 2008. Blood 112:4585. (Deplete) PubMed
  15. Kingeter LM, et al. 2008. J. Immunol. 181:6244. PubMed
  16. Guo Y, et al. 2008. Blood 112:480. PubMed
  17. Andrews DM, et al. 2008. J. Virol. 82:4931. PubMed
  18. Britschqui MR, et al. 2008. J. Immunol. 181:7681. PubMed
  19. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  20. Jordan JM, et al. 2008. Infect. Immun. 76:3717. PubMed
  21. Todd DJ, et al. 2009. J. Exp. Med. 206:2151. PubMed
  22. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  23. Medyouf H, et al. 2010. Blood 115:1175. PubMed
  24. Riedl P, et al. 2009. J. Immunol. 183:370. PubMed
  25. Apte SH, et al. 2010. J. Immunol. 185:998. PubMed
  26. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  27. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  28. Cui L, et al. 2015. J Control Release. 206:220. PubMed
  29. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  30. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  2. Su M, et al. 2018. Immunol Cell Biol. 9:2448. PubMed
  3. Porrello A, et al. 2018. Nat Commun. 9:1988. PubMed
  4. Webster P, et al. 2018. Nat Commun. 9:2649. PubMed
  5. Landon J Edgar et al. 2018. Cell chemical biology. 26(1):131-136 . PubMed
  6. Logan K Smith et al. 2018. Immunity. 48(2):299-312 . PubMed
  7. Sade–Feldman M, et al. 2018. Cell. 175:998. PubMed
  8. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  9. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  10. Bing Wu et al. 2018. Immunity. 49(5):886-898 . PubMed
  11. Gotoh K et al. 2018. Cell reports. 25(7):1800-1815 . PubMed
  12. Ibrahim ML, et al. 2018. Cell Rep. 25:3036. PubMed
  13. Ren S, et al. 2019. Oncol Rep. 41:1509. PubMed
  14. Yang H, et al. 2019. Mol Metab. 23:24. PubMed
  15. Li Y, et al. 2019. Sci Rep. 9:6932. PubMed
  16. Kim JH, et al. 2019. Mol Med. 25:33. PubMed
  17. Hebbandi Nanjundappa R, et al. 2017. Cell. 171:655. PubMed
  18. Budida R, et al. 2017. Eur J Immunol. 47:1819. PubMed
  19. Fang Y, et al. 2019. Aging (Albany NY). 11:4910. PubMed
  20. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  21. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  22. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  23. Zhang F, et al. 2019. Immunity. 50:738. PubMed
  24. Liu J, et al. 2019. Immunity. 50:600. PubMed
  25. Tanegashima K et al. 2017. EBioMedicine. 24:247-256 . PubMed
  26. Antonia O Cuff et al. 2017. Wellcome open research. 2:39 . PubMed
  27. Topper MJ et al. 2017. Cell. 171(6):1284-1300 . PubMed
  28. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  29. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  30. Wan X, et al. 2018. Nature. 560:107. PubMed
  31. Urata S, et al. 2018. PLoS Pathog. 14:e1007172. PubMed
  32. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  33. Denny JE, et al. 2019. Sci Rep. 2.786111111. PubMed
  34. Sivapatham S, et al. 2019. Front Immunol. 1.865277778. PubMed
  35. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  36. Raju S, et al. 2020. Cell Reports. 29(9):2556-2564.e3.. PubMed
  37. Blagih J, et al. 2020. Cell Rep. 30:481. PubMed
  38. Fu S, et al. 2020. Nat Commun. 0.7625. PubMed
  39. Li K, et al. 2020. Nat Commun. 0.795138889. PubMed
  40. Horkova V, et al. 2020. Cell Reports. 30(5):1504-1514.e7.. PubMed
  41. Du J, et al. 2018. AMB Express. 8:158. PubMed
  42. Lin W, et al. 2020. Theranostics. 10:4871. PubMed
  43. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  44. Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed
  45. Hu Z, et al. 2020. PLoS One. 15:e0228339. PubMed
  46. Panigrahy D, et al. 2019. J Clin Invest. 130:2964. PubMed
  47. Kos S, et al. 2019. PLoS One. 14:e0217762. PubMed
  48. Royzman D, et al. 2019. Front Immunol. 10:633. PubMed
  49. Fleskens V, et al. 2019. Cell Rep. 26:3600. PubMed
  50. Kim YS, et al. 2018. Front Immunol. 9:1093. PubMed
  51. Zhi Y, et al. 2020. Int J Mol Med. 45:1327. PubMed
  52. Strickley JD, et al. 2019. Nature. 575:519. PubMed
  53. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
  54. Zhang NN, et al. 2020. Cell. 182(5):1271-1283. PubMed
  55. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  56. Chakraborty P, et al. 2020. Cell Reports. 28(7):1879-1893.e7.. PubMed
  57. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  58. Dong MB, et al. 2020. Cell. 178(5):1189-1204.e23.. PubMed
  59. Treger RS, et al. 2020. Immunity. 50(2):334-347.e9.. PubMed
  60. Dulken BW, et al. 2019. Nature. 571:205. PubMed
  61. Bartolacci C, et al. 2018. Cancer Immunol Res. 1.281944444. PubMed
  62. Holman P, et al. 2005. J Immunol. 174:3986. PubMed
  63. Riedl P, et al. 2009. J Immunol. 183:370. PubMed
  64. Apte S, et al. 2010. J Immunol. 185:998. PubMed
  65. DeBerge M, et al. 2013. PLoS One. 8:79340. PubMed
  66. Schlecker E, et al. 2012. J Immunol. 189:5602. PubMed
  67. Wu S, et al. 2014. Clin Vaccine Immunol. 21:156. PubMed
  68. D'Cruz L, et al. 2014. J Immunol. 192:2227. PubMed
  69. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  70. Kvell K, et al. 2014. Immunobiology. 219:644. PubMed
  71. Roderick J, et al. 2014. Proc Natl Acad Sci U S A. 111:14436. PubMed
  72. Morales D, et al. 2015. J Virol. 89:337. PubMed
  73. Shen L, et al. 2015. Cancer Immunol Res. 3:136. PubMed
  74. Drees J, et al. 2015. Anticancer Res. 35:843. PubMed
  75. Hao B, et al. 2015. J Exp Med. 212:809. PubMed
  76. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  77. Artinger K, et al. 2015. PLoS One. 10: 0135087. PubMed
  78. Paschall A, et al. 2015. J Immunol. 194: 2369-2379. PubMed
  79. Wang L, et al. 2015. Cancer Immunol Res. 3: 1030-1041. PubMed
  80. Calderon B, et al. 2015. J Exp Med. 212: 1497-1512. PubMed
  81. Ito C, et al. 2015. PLoS One. 10: e0140808. PubMed
  82. Yasuma K, et al. 2016. PLoS Pathog. 12: 1005372. PubMed
  83. Martina M, et al. 2016. J Am Soc Nephrol. 27: 1113-1123. PubMed
  84. Kawano H, et al. 2016. Int Immunol. 28: 489 - 501. PubMed
  85. Li Y, Kaneda T 2016. Sci Rep. 6: 25077. PubMed
  86. Nicolay N, et al. 2016. Sci Rep. 6: 26645. PubMed
  87. Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed
  88. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  89. Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed
  90. Knocke S, et al. 2016. Cell Rep. 17:2234-2246. PubMed
  91. Miura N, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.020. PubMed
  92. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  93. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  94. Li X, et al. 2020. Nat Commun. 4.877777778. PubMed
  95. Hayashi K, et al. 2020. Nat Commun. 4.832638889. PubMed
  96. Len-Letelier RA, et al. 2020. Frontiers in Immunology. 11:583382. PubMed
  97. Köchl R, et al. 2020. Elife. 9:00. PubMed
  98. Yang J, et al. 2020. Nature. 586:572. PubMed
  99. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  100. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  101. Gerwing M, et al. 2020. Mol Imaging Biol. 1.959027778. PubMed
  102. Perry JL, et al. 2020. ACS Nano. 5.583333333. PubMed
  103. Lutes LK, et al. 2021. eLife. 10:00. PubMed
  104. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  105. Lv H, et al. 2020. Cell Metabolism. 33(1):110-127.e5. PubMed
  106. Shen JZ, et al. 2020. Cell. 184(2):352-369.e23. PubMed
  107. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  108. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  109. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  110. Yi W, et al. 2021. Cell Reports. 34(13):108922. PubMed
  111. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  112. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  113. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  114. Altshuler A, et al. 2021. Cell Stem Cell. 28(7):1248-1261.e8. PubMed
  115. Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed
  116. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
  117. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  118. Magod P, et al. 2021. Cell Reports. 36(5):109480. PubMed
  119. Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed
  120. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  121. Okamoto T, et al. 2020. Cancer Res. 3580:80. PubMed
  122. Yan J, et al. 2020. Cell Rep. 107820:31. PubMed
  123. Xie L, et al. 2020. Infect Immun. :88. PubMed
  124. Crowe JL, et al. 2020. Proc Natl Acad Sci U S A. 22953:117. PubMed
  125. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  126. Luff DH, et al. 2021. Front Immunol. 631271:12. PubMed
  127. Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed
  128. Wu J, et al. 2020. Immunity. 53:115. PubMed
  129. Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed
  130. Seo YB, et al. 2021. Vaccines (Basel). 9: . PubMed
  131. Wu Y, et al. 2021. Nat Commun. 12:2346. PubMed
  132. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  133. Yang F, et al. 2021. Nat Commun. 12:3424. PubMed
  134. Wen X, et al. 2021. World J Gastroenterol. 27:2834. PubMed
  135. Wang K, et al. 2021. Nat Commun. 12:4558. PubMed
  136. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  137. Huang Z, et al. 2021. Nat Commun. 12:145. PubMed
  138. Tsyklauri O, et al. 2021. EMBO Rep. 22:e50785. PubMed
  139. Petriv N, et al. 2021. Oncoimmunology. 10:1874159. PubMed
  140. Gu Z, et al. 2021. Nat Genet. 53:672. PubMed
  141. Grioni M, et al. 2021. Blood Adv. 5:2817. PubMed
  142. Matundan HH, et al. 2021. J Virol. 95:e0103621. PubMed
  143. Wang F, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:257. PubMed
  144. Ren Y, et al. 2021. Nat Commun. 12:5405. PubMed
  145. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  146. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  147. Huang L, et al. 2021. Breast Cancer Res Treat. Online ahead of print. PubMed
  148. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  149. Fang F, et al. 2021. Cell Rep. 37:109981. PubMed
  150. Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed
  151. MacDonald A, et al. 2021. Front Immunol. 12:755995. PubMed
  152. Gu Y, et al. 2021. Cell Res. Online ahead of print. PubMed
  153. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  154. Berghoff SA, et al. 2021. Nat Neurosci. 24:47. PubMed
  155. Akhtar MN, et al. 2020. PLoS Pathog. 16:e1009136. PubMed
  156. Suah AN, et al. 2021. J Clin Invest. 131:. PubMed
  157. Dodagatta-Marri E, et al. 2021. Cell Rep. 36:109309. PubMed
  158. Bosnjak B, et al. 2021. Front Immunol. 12:772240. PubMed
  159. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  160. Zhan L, et al. 2022. Cancer Lett. 529:37. PubMed
  161. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  162. Sun C, et al. 2022. J Adv Res. 35:71. PubMed
  163. Wang X, et al. 2022. Elife. 11:. PubMed
  164. Wang Y, et al. 2022. Acta Pharm Sin B. 12:262. PubMed
  165. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  166. Zebley CC, et al. 2021. Cell Rep. 37:109796. PubMed
  167. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  168. Castellanos CA, et al. 2021. Sci Immunol. 6:eabh0707. PubMed
  169. Li H, et al. 2022. iScience. 25:104481. PubMed
  170. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  171. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  172. Wu K, et al. 2021. Aging (Albany NY). 13:. PubMed
  173. Li M, et al. 2021. Cancers (Basel). 13:. PubMed
  174. Lee S, et al. 2021. Autophagy. 18:1062. PubMed
  175. Pishesha N, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  176. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  177. Zheng D, et al. 2022. Acta Pharm Sin B. 12:2740. PubMed
  178. Mukherjee D, et al. 2022. Nat Commun. 13:3747. PubMed
  179. Jin C, et al. 2022. Oncoimmunology. 11:2099642. PubMed
  180. Taddeo A, et al. 2022. NPJ Vaccines. 7:82. PubMed
  181. Liu B, et al. 2022. Mol Med Rep. 26:. PubMed
  182. Kung YJ, et al. 2022. J Biomed Sci. 29:57. PubMed
  183. Wang R, et al. 2022. Front Immunol. 13:947756. PubMed
  184. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  185. Kim S, et al. 2022. Cancers (Basel). 14:. PubMed
  186. Li X, et al. 2022. Oncoimmunology. 11:2118210. PubMed
  187. He C, et al. 2022. Nat Commun. 13:5459. PubMed
  188. Wang Q, et al. 2020. Wound Repair Regen. 28:105. PubMed
  189. Zhang Z, et al. 2020. Nature. 579:415. PubMed
  190. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  191. Wu P, et al. 2020. Cancer Immunol Res. 8:1470. PubMed
  192. Soria-Castro R, et al. 2020. Sci Rep. 10:17802. PubMed
  193. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  194. Ying B, et al. 2022. Sci Transl Med. 14:eabm3302. PubMed
  195. Wu MJ, et al. 2022. Cancer Discov. 12:812. PubMed
  196. Nikolos F, et al. 2022. Nat Commun. 13:1487. PubMed
  197. Li Q, et al. 2022. Front Oncol. 12:841977. PubMed
  198. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  199. Yao RQ, et al. 2022. Theranostics. 12:4606. PubMed
  200. Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed
  201. Feng D, et al. 2022. Nat Commun. 13:5554. PubMed
  202. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  203. Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed
  204. Yu Y, et al. 2022. Nat Commun. 13:6357. PubMed
  205. Greenberg J, et al. 2022. JCI Insight. Online ahead of print. PubMed
  206. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  207. Tu X, et al. 2022. Nat Commun. 13:6977. PubMed
  208. Milanovic M, et al. 2021. Cancer Res. 81:426. PubMed
  209. Aimaitijiang A, et al. 2022. Genes Cells. 27:25. PubMed
  210. Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed
  211. Martin-Martin I, et al. 2022. Cell Rep. 39:110648. PubMed
  212. Corral D, et al. 2022. Cell Rep. 39:110715. PubMed
  213. Lu R, et al. 2022. Scand J Immunol. 96:e13177. PubMed
  214. Chowdhury S, et al. 2022. Cancer Res. 82:2640. PubMed
  215. Tessaro FHG, et al. 2022. Cell Rep. 39:110977. PubMed
  216. Liu W, et al. 2022. Biomedicines. 10: . PubMed
  217. Deng P, et al. 2022. J Clin Invest. 132: . PubMed
  218. Sun Y, et al. 2023. Bioact Mater. 22:47. PubMed
  219. Li J, et al. 2022. Front Immunol. 13:1043484. PubMed
  220. Roy S, et al. 2022. Am J Cancer Res. 12:4977. PubMed
  221. Weng S, et al. 2022. Front Immunol. 13:1025931. PubMed
  222. Ding L, et al. 2023. J Clin Invest. 133: . PubMed
  223. Choi H, et al. 2023. J Nanobiotechnology. 21:5. PubMed
  224. Wang L, et al. 2022. Nutrients. 15: . PubMed
  225. Zhang B, et al. 2023. Signal Transduct Target Ther. 8:28. PubMed
  226. Elliot TAE, et al. 2022. Discov Immunol. 1:kyac009. PubMed
  227. Kemna J, et al. 2023. Nat Immunol. 24:414. PubMed
  228. Wang J, et al. 2023. Inflamm Regen. 43:12. PubMed
  229. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  230. Milanovic M, et al. 2021. J Immunol. 206:1228. PubMed
  231. Dragan M, et al. 2022. J Invest Dermatol. 142:583. PubMed
  232. Wei J, et al. 2022. Cancer Prev Res (Phila). 15:285. PubMed
  233. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  234. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  235. Lee KM, et al. 2022. Cancer Immunol Res. 10:829. PubMed
  236. Puth S, et al. 2022. Biomaterials. 286:121542. PubMed
  237. Alghamri MS, et al. 2022. ACS Nano. 16:8729. PubMed
  238. Edwards KJ, et al. 2022. Cancer Immunol Res. 10:1084. PubMed
  239. Akhtar MN, et al. 2022. MBio. 13:e0330921. PubMed
  240. Konjar S, et al. 2022. Proc Natl Acad Sci U S A. 119:e2202144119. PubMed
  241. Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed
  242. Ma X, et al. 2023. Nat Commun. 14:1606. PubMed
  243. Zhuang WR, et al. 2023. Nat Commun. 14:1675. PubMed
  244. Li D, et al. 2023. Ann Med. 55:2189295. PubMed
  245. Bhatia V, et al. 2023. Nat Commun. 14:2041. PubMed
  246. Chen F, et al. 2023. Acta Biomater. 164:387. PubMed
  247. Li Y, et al. 2023. Front Cell Infect Microbiol. 13:1117230. PubMed
  248. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  249. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  250. Park HJ, et al. 2023. NPJ Vaccines. 8:84. PubMed
  251. Seo YB, et al. 2023. Int J Mol Sci. 24:. PubMed
  252. Pagano G, et al. 2023. Haematologica. . PubMed
RRID
AB_312744 (BioLegend Cat. No. 100705)
AB_312745 (BioLegend Cat. No. 100706)

Antigen Details

Structure
Ig superfamily, CD8α chain, 34 kD
Distribution

Most thymocytes, T cell subset, some NK cells, lymphoid dendritic cells

Function
Co-receptor for TCR
Ligand/Receptor
MHC class I molecule
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Zamoyska R. 1994. Immunity 1:243.
3. Ellmeier W, et al. 1999. Annu. Rev. Immunol. 17:523.

Gene ID
12525 View all products for this Gene ID
UniProt
View information about CD8alpha on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 2    Revision Date: 01/21/2014

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account